ClinConnect ClinConnect Logo
Search / Trial NCT05862103

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Launched by YU BO · May 8, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acute Myocardial Infarction Major Adverse Cardiac And Cerebrovascular Event Optimized Treatment

ClinConnect Summary

This clinical trial is following up with patients who have survived an acute myocardial infarction, which is a serious heart event commonly known as a heart attack. The study aims to gather information about the long-term health and medication use of these patients. It specifically looks at important health events that may occur after the heart attack, such as additional heart problems, strokes, or even death. The researchers are reaching out to patients by phone three years and five years after they were discharged from the hospital to collect this information.

To participate in this trial, you need to have been part of a previous study focusing on heart protection and completed a health check one year after your heart attack. The trial is open to all adults aged 65 and older who meet these criteria. If you choose to take part, you can expect a phone call from the research team to discuss your current health and any heart-related issues you've experienced since your initial treatment. This follow-up is important to help doctors understand how survivors of heart attacks are doing over time and to improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
  • Telephone to obtain informed consent from the subjects/family members of the subjects.
  • Exclusion Criteria:
  • Not available

About Yu Bo

Yu Bo is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to improving patient outcomes, Yu Bo specializes in the development and management of clinical studies across various therapeutic areas. The organization emphasizes rigorous scientific methodologies and regulatory compliance, ensuring the highest standards of quality and safety in all trials. By fostering collaboration with healthcare professionals and research institutions, Yu Bo aims to accelerate the discovery of novel treatments and contribute to the enhancement of global health.

Locations

Beijing, Beijing, China

Guangzhou, Guangdong, China

Zhengzhou, Henan, China

Nanning, Guangxi, China

Nanchang, Jiangxi, China

Nanjing, Jiangsu, China

Daqing, Heilongjiang, China

Beijing, Beijing, China

Tianjin, Tianjin, China

Beijing, Beijing, China

Beijing, Beijing, China

Tianjing, Tianjin, China

ürümqi, Xinjiang, China

Shijiazhuang, Hebei, China

Chongqing, Sichuan, China

Changchun, Jilin, China

Dalian, Liaoning, China

Shenyang, Liaoning, China

Xi'an, Shanxi, China

Patients applied

0 patients applied

Trial Officials

Bo Yu

Study Chair

The Second Affiliated Hospital of Harbin Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported